Precigen (PGEN) Assets Average (2013 - 2026)
Precigen's (PGEN) quarterly Assets Average came in at $147.1 million in Q1 2026, up 7.33% year-on-year from $137.0 million in Q1 2025, and down 9.99% on a QoQ basis from $163.4 million in Q4 2025.
Precigen (PGEN) Assets Average (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Assets Average data on file, last reported at $147.1 million in Q1 2026.
- On a quarterly basis, Assets Average rose 7.33% year-over-year to $147.1 million in Q1 2026; TTM through Mar 2026 was $147.1 million, a 7.33% increase from a year earlier, with the FY2025 full-year figure at $150.4 million, up 1.51% from the prior year.
- Assets Average for Q1 2026 stood at $147.1 million, down from $163.4 million in the prior quarter.
- Over the last five years, Assets Average for PGEN reached as high as $347.7 million in Q1 2022 and fell as low as $78.3 million in Q3 2024.
- Historically, Assets Average has averaged $186.3 million across 5 years, with a median of $163.4 million in 2025.
- Across the five-year window, Assets Average sank 60.67% in 2024 and soared 74.39% in 2025, its largest moves.
- Year by year, Assets Average stood at $237.6 million in 2022, then dropped by 28.09% to $170.9 million in 2023, then tumbled by 33.06% to $114.4 million in 2024, then jumped by 42.86% to $163.4 million in 2025, then decreased by 9.99% to $147.1 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $147.1 million in Q1 2026, $163.4 million in Q4 2025, and $136.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | 147.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.07 Mn |
| Dec 31, 2025 | 163.38 Mn |
| Sep 30, 2025 | 136.58 Mn |
| Jun 30, 2025 | 115.34 Mn |
| Mar 31, 2025 | 137.03 Mn |
| Dec 31, 2024 | 114.37 Mn |
| Sep 30, 2024 | 78.32 Mn |
| Jun 30, 2024 | 104.00 Mn |
| Mar 31, 2024 | 142.95 Mn |
| Dec 31, 2023 | 170.87 Mn |
| Sep 30, 2023 | 199.11 Mn |
| Jun 30, 2023 | 224.54 Mn |
| Mar 31, 2023 | 228.76 Mn |
| Dec 31, 2022 | 237.61 Mn |
| Sep 30, 2022 | 290.23 Mn |
| Jun 30, 2022 | 328.40 Mn |
| Mar 31, 2022 | 347.71 Mn |
| Dec 31, 2021 | 368.38 Mn |
| Sep 30, 2021 | 389.74 Mn |
| Jun 30, 2021 | 404.78 Mn |